CAS 59831-65-1: Halopemide
Description:Halopemide is a chemical compound classified as a benzamide derivative, primarily known for its application in the field of pharmacology. It is recognized for its potential use as an antipsychotic agent, exhibiting properties that may influence neurotransmitter systems in the brain, particularly those involving dopamine and serotonin. The molecular structure of Halopemide includes a halogenated aromatic ring, which contributes to its biological activity. It is typically characterized by its moderate solubility in organic solvents and limited solubility in water, which can affect its bioavailability and pharmacokinetics. The compound has been studied for its effects on various neurological conditions, although its clinical use may be limited compared to other antipsychotics. Safety and efficacy profiles are essential considerations in its application, and ongoing research may further elucidate its therapeutic potential and mechanisms of action. As with any pharmaceutical compound, proper handling and adherence to safety guidelines are crucial due to potential side effects and interactions with other medications.
Formula:C21H22ClFN4O2
InChI:InChI=1/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29)
- Synonyms:
- 59831-65-1
- N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluorobenzamide
- N-{2-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]ethyl}-4-fluorobenzamide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Halopemide REF: 54-BUP14311CAS: 59831-65-1 | 96.28% | 371.00 €~3,454.00 € | Thu 17 Apr 25 |
![]() | Halopemide REF: TR-H103695CAS: 59831-65-1 | - - - | 2,353.00 € | Tue 27 May 25 |
![]() | Halopemide REF: TM-T15461CAS: 59831-65-1 | 96.29% | 34.00 €~530.00 € | Wed 04 Jun 25 |
![]() | N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide REF: 3D-FC145515CAS: 59831-65-1 | Min. 95% | - - - | Discontinued product |

Ref: 54-BUP14311
25mg | 371.00 € | ||
50mg | 544.00 € | ||
100mg | 791.00 € | ||
200mg | 1,415.00 € | ||
500mg | 3,454.00 € |

Halopemide
Controlled ProductRef: TR-H103695
100mg | 2,353.00 € |

Halopemide
- Inhibitors
- Metabolism
- Phospholipase
- Dopamine Receptor
- See more categories
- Cancer Research Antibodies
Ref: TM-T15461
1mg | 34.00 € | ||
5mg | 85.00 € | ||
10mg | 126.00 € | ||
25mg | 245.00 € | ||
50mg | 364.00 € | ||
100mg | 530.00 € | ||
1mL*10mM (DMSO) | 94.00 € |

N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide
Ref: 3D-FC145515
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information |